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Epicardial formation and coronary vasculogenesis are highly regulated processes that involve a series of spatio-
temporally regulated molecular and cellular events.1,2 These 
processes begin with formation of the proepicardial organ 
(PEO)/proepicardium and involve epicardial-derived cell 
(EPDC) transition. The PEO is located at the venous pole of 
the heart and is part of the septum transversum. This transitory 
structure is comprised of mesothelial cells morphologically 
visible in the mouse between embryonic day (E) 9 and 9.5.1 At 
E10.5, the epicardium is formed and fully matured by E11.5. A 
subset of epicardial cells undergoes epithelial–mesenchymal 
transition (EMT) to generate EPDCs that delaminate and 
populate the subepicardial space and further migrate into the 
underlying myocardium.1,3 Here, they differentiate into the 
cellular elements of coronary blood vessels (ie, endothelial 
cells, smooth muscle cells [SMC], and cardiac fibroblasts). 
Subepicardial endothelial cells contribute to both coronary 
arteries and veins.4 The sinus venosus and endocardium also 
contribute coronary endothelial cells to form the developing 
coronary arteries.5,6 Subsequently, these cellular components 
coalesce and form the primitive vascular plexus that ultimate-
ly remodels to form the coronary blood vessels. Using various 
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Rationale: Holt–Oram syndrome is an autosomal dominant heart-hand syndrome caused by mutations in the 
TBX5 gene. Overexpression of Tbx5 in the chick proepicardial organ impaired coronary blood vessel formation. 
However, the potential activity of Tbx5 in the epicardium itself, and the role of Tbx5 in mammalian coronary 
vasculogenesis, remains largely unknown.
Objective: To evaluate the consequences of altered Tbx5 gene dosage during proepicardial organ and epicardial 
development in the embryonic chick and mouse.
Methods and Results: Retroviral-mediated knockdown or upregulation of Tbx5 expression in the embryonic 
chick proepicardial organ and proepicardial-specific deletion of Tbx5 in the embryonic mouse (Tbx5epi-/) impaired 
normal proepicardial organ cell development, inhibited epicardial and coronary blood vessel formation, and 
altered developmental gene expression. The generation of epicardial-derived cells and their migration into the 
myocardium were impaired between embryonic day (E) 13.5 to 15.5 in mutant hearts because of delayed epicardial 
attachment to the myocardium and subepicardial accumulation of epicardial-derived cells. This caused defective 
coronary vasculogenesis associated with impaired vascular smooth muscle cell recruitment and reduced invasion 
of cardiac fibroblasts and endothelial cells into myocardium. In contrast to wild-type hearts that exhibited an 
elaborate ventricular vascular network, Tbx5epi-/- hearts displayed a marked decrease in vascular density that was 
associated with myocardial hypoxia as exemplified by hypoxia inducible factor-1α upregulation and increased 
binding of hypoxyprobe-1. Tbx5epi-/- mice with such myocardial hypoxia exhibited reduced exercise capacity when 
compared with wild-type mice.
Conclusions: Our findings support a conserved Tbx5 dose-dependent requirement for both proepicardial 
and epicardial progenitor cell development in chick and in mouse coronary vascular formation.  
 (Circ Res. 2014;115:834-844.)
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mouse models with Cre-recombinase expressed in epicardial 
and/or EPDCs, investigators have demonstrated multiple con-
tributions of EPDCs to coronary smooth muscle, coronary 
endothelium, the interstitial fibroblast population, and the 
atrioventricular junctional myocardium.1,2,7–10
The epicardium plays a pivotal role in cardiac development 
because paracrine-mediated secretion of epicardial factors, 
such as Wnts, erythropoietin, fibroblast growth factors, and 
retinoids, are important for embryonic compact myocardial 
growth1,2 and can be reactivated during cardiac injury and re-
pair.11 PEO ablation/blockade that perturbs or delays epicar-
dial formation and genetic ablation of various genes expressed 
in the proepicardium or myocardium leads to abnormal coro-
nary vasculogenesis, myocardial defects, and potential embry-
onic lethality.1,2
T-box transcription factor genes, including Tbx5 and 
Tbx18, are expressed in the PEO or septum transversum.1,12–15 
We previously showed that the manipulation of Tbx5 gene 
dosage in the chick PEO affects proepicardial cell migration 
and can impair avian coronary vasculogenesis.16 However, 
these studies did not address the potential activity of Tbx5 
in the epicardium itself. The mechanisms by which Tbx5 
controls mammalian coronary vasculogenesis remain largely 
unknown, and the relevance of avian signaling to mammalian 
ontogeny was not tested. Holt–Oram syndrome (HOS) is a 
human inherited disorder caused by mutations in TBX5 and 
manifests as congenital cardiac septation and conduction de-
fects in the setting of limb deformities.17,18 Some patients with 
HOS also exhibit left pericardium agenesis and anomalous 
coronary arteries along with ventricular septal defects19,20 
consistent with a role for TBX5 in epicardial/pericardial and 
myocardial development. Early embryonic lethality resulting 
from germline inactivation of Tbx5 in the mouse has preclud-
ed further investigation of the function of Tbx5 in later stages 
of cardiac development, including epicardial formation and 
coronary vasculogenesis.21
We have now developed strategies to investigate epicar-
dial activity of Tbx5 in the chick, and we have generated 
conditional mutant mice with Tbx5 deletion from the proepi-
cardial and epicardial derivatives. We show that Tbx5 expres-
sion in the proepicardium/PEO and epicardium is required for 
normal development of proepicardium/PEO cells, as well as 
proper epicardial formation and maturation. Tbx5 deficiency 
delays epicardial cell attachment to the myocardium, impairs 
production of EPDCs and their migration into the myocar-
dium, and results in abnormal coronary vasculogenesis and 
murine ischemic cardiomyopathy. Our findings demonstrate 
that Tbx5 is required both for proepicardial and for epicardial 
development in avian and in mammalian hearts and for estab-
lishment of the coronary vasculature.
Methods
Tbx5lox/lox 21 and Wilm’s tumor 1 (Wt1)-Cre8,22 mice have been de-
scribed. Generation of retrovirus and in ovo retroviral injection was 
performed as previously described16 with the exception of epicardial 
infection that was accomplished by retroviral injection into the peri-
cardial space of the embryonic chick.
An expanded Methods section, including all experimental proce-
dures, is available in the Online Data Supplement.
Results
Tbx5 Expression in Chick and Mouse PEO and 
Derivatives
Although Tbx5 myocardial and endocardial expressions have 
been previously described during cardiogenesis,16,23,24 the de-
tailed spatiotemporal patterns of chick and mouse Tbx5 ex-
pression in the PEO/proepicardium and epicardium have not 
been well defined. In situ hybridization in chick embryos 
revealed heterogeneous staining in the PEO at Hamburger–
Hamilton (HH) stage 16 or E3 (Online Figure IA and IE). By 
HH22 (E4), chick Tbx5 (cTbx5) remained detectable in the 
PEO remnant and in migrating proepicardial cells contacting 
the myocardium. By HH26 (E5), cTbx5 was evident in the 
newly formed epicardium (Online Figure IB and IF). A simi-
lar expression pattern for mouse Tbx5 (mTbx5) was observed 
by in situ hybridization at the corresponding developmental 
stages of E9.5 (Online Figure IC and IG) and E10.5 in the 
mouse (Online Figure ID and IH). Immunostaining for mTbx5 
protein expression showed a spatiotemporal pattern similar to 
that observed with our in situ hybridization data. At E9.5, nu-
clear expression of mTbx5 protein was evident in the murine 
proepicardium in a heterogeneous pattern (Online Figure II 
and IL). At E10.5, mTbx5 protein expression was evident in 
the nascent epicardium and pericardium (Online Figure IJ). 
Whereas some epicardial cells were Tbx5-negative (online 
Figure IM), all epicardial cells expressed Wt1 (Online Figure 
IN). Tbx5 expression was decreased in the epicardial cells by 
E11.5 (Online Figure IK and IO), but persists into adulthood 
as previously shown.25
 Thus, these analyses support spatial 
and temporal restriction of Tbx5 expression in the embryonic 
chick and murine PEO/proepicardium and epicardium.
Tbx5 Contributes to In Vitro and In Vivo 
Proepicardial Cell Development
We previously demonstrated that Tbx5 overexpression dis-
rupts chick proepicardial cell migration in vitro.16 To de-
termine the requirement for cTbx5 in epicardial formation 
and coronary vasculogenesis, we used retroviral-mediated 
Nonstandard Abbreviations and Acronyms
cTbx5  chick Tbx5
cTbx5As-CXL CXL retrovirus encoding antisense chick Tbx5
CXIZ  control retrovirus encoding β-galactosidase
E  embryonic day
ECM  extracellular matrix
EMT  epithelial–mesenchymal transformation
EPDCs  epicardial-derived cells
HH  Hamburger-Hamilton
HOS  Holt–Oram syndrome
mTbx5  mouse Tbx5
PEO  proepicardial organ
SMC  smooth muscle cell
SM22α  smooth muscle 22 α (transgelin)
Tbx  T-box
Tbx5epi-/-  Tbx5lox/lox;Wt1-Cre
Wt1  Wilm’s tumor 1
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transgenesis with an antisense (cTbx5As-CXL) construct 
(Online Figure IIA) to knock down cTbx5 expression in 
cultured PEO explants in a manner similar to our previous 
TBX5 overexpression studies.16 Retroviral-mediated cTbx5 
knockdown produced a 45% reduction of in vitro migration 
of proepicardial cells to the periphery of PEO explants com-
pared with control CXL PEOs (Online Figure IIIA–IIIC). 
This demonstrated that cTbx5 expression is required for in 
vitro chick proepicardial cell migration.
To confirm that this requirement for cTbx5 was preserved 
in PEO cell migration and coronary vasculogenesis in vivo, 
we injected either control CXL26 or cTbx5As-CXL retrovirus 
into chick PEOs in ovo at HH17-18 (E3; Online Figure IIA). 
By 8 hours after injection, we observed transgene expression 
in the PEO as shown by X-gal staining for β-galactosidase 
activity for both retroviruses (Figure 1A and 1E). Twenty-
four hours after PEO injection with the control CXL virus, 
β-galactosidase–positive cells were visible on the surface of 
the heart (Figure 1B). However, embryos that received PEO 
injections of cTbx5As-CXL to knock down Tbx5 expression 
exhibited only scant β-galactosidase–positive cells on the sur-
face of the heart (Figure 1F). By 12 days after injection, E15 
CXL-infected embryos (15/15 embryos) displayed prominent 
β-galactosidase–positive staining in the coronary vasculature 
(Figure 1C and 1D). Hearts from E15 embryos infected with 
cTbx5As-CXL did not show any evidence of β-galactosidase 
staining in the coronary vessels (0/13 embryos; Figure 1G). 
All hearts exhibited minimal levels of myocardial staining at 
24 hours to 12 days after injection because of slight retrovi-
ral leakage into the myocardium during the initial pressure 
injection of the retrovirus as evidenced by β-galactosidase 
staining of myocardial cells in E15 hearts (Figure 1C and 1G). 
This staining confirmed the infectivity of all viruses. Thus, 
maintenance of normal Tbx5 expression in the chick PEO is 
required for proper development of the epicardium and coro-
nary vasculature.
Tbx5 Contributes to Chick Epicardial Cell Fate and 
Coronary Artery Development
To determine whether Tbx5 activity during coronary vas-
culogenesis is required in the epicardium independent of 
its activity in the PEO, we used retroviral-mediated trans-
genesis to augment or knock down Tbx5 in the nascent epi-
cardium in vivo directly. We microinjected either the same 
retroviruses as described above or control retrovirus encoding 
β-galactosidase (CXIZ) and TBX5-CXIZ retrovirus27 (Online 
Figure IIA) into the pericardial space (Online Figure IIB) at 
later stages of development (E4) when the epicardium had 
largely already formed. This produces transgenesis of the 
nascent epicardium (Figure 1I–1P). Because epicardium for-
mation was not fully completed at this stage, areas of naked 
myocardium were exposed to viruses with this strategy, and 
the presence of infected myocardium in each embryo pro-
vided a positive control for viral infectivity. β-galactosidase–
positive cells demonstrated infectivity of the epicardium at 
8 (Figure 1I) and 24 hours (Figure 1J) after injection for all 
viruses. By 11 days after injection, β-galactosidase–positive 
cells were visible in the coronary blood vessels of most E15 
CXL- and CXIZ-injected control embryos (21/23 CXL em-
bryos; Figure 1K and 1L; 22/23 CXIZ embryos [not shown]). 
Altered embryonic epicardial Tbx5 expression (knockdown 
with cTbx5As-CXL [1/15 embryos]; Figure 1M and 1N) or 
overexpression with TBX5-CXIZ (0/18 embryos; Figure 1O 
and 1P) inhibited incorporation of infected cells into the 
coronary vasculature. These hearts displayed only sparse and 
patchy β-galactosidase–positive cells in the myocardium and 
Figure 1. Knockdown and overexpression 
of Tbx5 affects proepicardial organ (PEO) 
cell development. A–P, Retroviral-mediated 
manipulation of Tbx5 gene dosage in ovo.  
β-galactosidase activity in whole mount hearts 
at 8 hours (A, E, I), 24 hours (B, F, J), and at E15 
(C, D, G, H, K–P) after either in ovo PEO retroviral 
microinjection at HH16 with control CXL (A–D) 
and cTbx5As-CXL (E–H) retroviruses or in ovo 
epicardial infection at HH23 with control CXL (I–L), 
cTbx5As-CXL (M and N) and TBX5-CXIZ (O and 
P) retroviruses. Arrows indicate β-galactosidase–
positive PEO cells (A and E), epicardial cells (H), 
and also coronary vessels with (D and L) or without 
(N and P) β-galactosidase activity. Scale bars,  
100 μm (A–P).
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epicardium (Figure 1N and 1P). Thus, maintenance of nor-
mal Tbx5 dosage in the epicardium is required for its proper 
maturation and the subsequent incorporation of EPDCs into 
coronary blood vessels.
To investigate cellular mechanisms underlying impaired 
epicardial cell development, we examined the effect of cTbx5 
augmentation on in vitro PEO cell behavior. We previously 
demonstrated that in vitro TBX5 overexpression in PEO ex-
plants impaired migration of proepicardial cells out of these 
TBX5-CXIZ–infected PEO explants but did not affect PEO 
cell proliferation.16 In addition to our previous observa-
tions, we now detect some apoptotic migratory proepicardial 
cells outside of the PEO explants (Online Figure IIID–IIIF). 
Apoptosis was not observed in control CXIZ-infected migra-
tory proepicardial cells. Thus, in vitro augmentation of pro-
epicardial cTbx5 not only impaired migration of proepicardial 
cells, but also caused apoptosis in some migratory proepicar-
dial cells.
Epicardial Inactivation of Murine Tbx5 Affects 
Formation and Maturation of the Epicardium and 
Migration of EPDCs
In the mouse, ubiquitous deletion of mTbx5 caused embryonic 
lethality by E10.5 that previously precluded analysis of coro-
nary vasculogenesis.21 We circumvented this barrier by con-
ditional tissue-specific ablation of Tbx5 in the proepicardium 
and its derivatives. We crossed C57Bl/6 female Tbx5 condi-
tional knockout mice (Tbx5lox/lox)21 with C57Bl/6 male Wt1-
Cre driver mice that express Cre-recombinase in proepicardial 
and epicardial cells.8,22 Male progeny (Tbx5epi+/-) exhibiting 
excision of 1 Tbx5 floxed allele and carrying the Cre trans-
gene were crossed against female Tbx5lox/lox to generate mice 
with 2 floxed alleles excised in proepicardial cells, and hereaf-
ter referred to as Tbx5lox/lox;Wt1-Cre (Tbx5epi-/-). We confirmed 
Cre-mediated deletion of Tbx5 and diminished Tbx5 mRNA 
expression in proepicardial cells of Tbx5epi-/- versus wild-type 
control mice (Online Figure IVA–IVE). Tbx5epi-/- mice were 
born at significantly reduced Mendelian ratios compared with 
control mice (P=0.03; Online Figure IVF).
We analyzed Tbx5epi-/- embryos at various developmental 
stages to gain insight into the cause of lethality. Examination 
of whole mount and sectioned hearts from E9.5 wild-type 
and mutant mice revealed that both wild-type (Figure 2A and 
2B) and Tbx5epi-/- (Figure 2D and 2E) embryos form a pro-
epicardium and express the proepicardial and epicardial cell 
marker, Wt1, in the proepicardium at E9.5 (Figure 2C and 
2F). Although proepicardium specification appeared normal 
in Tbx5epi-/- embryos, mutant proepicardiums (Figure 2D–2F) 
often appeared smaller relative to wild-type proepicardiums 
(Figure 2A–2C). Analyses of in vivo cell behavior by Ki-67 
immunostaining (Online Figure VA–VD) and terminal deoxy-
nucleotidyl transferase dUTP nick end labeling (not shown) 
revealed unmodified rates of proliferation (Online Figure 
VE), and no evidence of increased apoptosis, respectively, in 
Tbx5epi-/- proepicardial cells was observed. Furthermore, our 
examination of proepicardial cell polarity in these embryos did 
not reveal altered expression or localization of apical (PAR3, 
ezrin), basolateral (α4-integrin), and cell–cell junctional (ZO-
1) markers28 between wild-type and mutant proepicardiums at 
E9.5. These data indicated that Tbx5 deficiency did not alter 
proepicardial cell proliferation, apoptosis, or polarity.
The epicardial cell layer, as indicated by Wt1-positive cells, 
began to form on the myocardial surface of E10.5 wild-type 
and Tbx5epi-/- hearts (not shown). Although a smooth-surfaced 
epicardium was observed in E11.5 wild-type hearts (Figure 2G 
and 2H), the epicardium in Tbx5epi-/- hearts appeared irregu-
lar and ruffled with focal regions that were unattached to the 
myocardium (Figures 2I and 2J). However, Wt1-positive epi-
cardial cells were attached to the myocardium in both wild-
type (Figure 3A) and Tbx5epi-/-(Figure 3D) hearts by E12.5. 
These data indicate that deletion of Tbx5 delayed adhesion 
of the epicardial cell layer to the myocardium, and Tbx5 is 
important for proper structural formation of the epicardium.
Within the subepicardial space of E13.5 wild-type and mutant 
hearts, Wt1-positive epicardial cells began to delaminate and 
EPDCs began invading the compact myocardium (Figure 3B 
and 3E). Nonetheless, fewer Wt1-positive EPDCs invaded the 
compact myocardium of E13.5 mutant hearts (Figure 3E). We 
observed focal accumulation of Wt1-positive cells in the sub-
epicardium of E14.5 mutant embryos (Figure 3F) when com-
pared with wild-type littermates (Figure 3C). Quantification 
of these cells in the compact myocardium of E14.5 mice re-
vealed a 48.5% reduction in Wt1-positive EPDCs in Tbx5epi-/- 
hearts versus wild-types (Figure 3G). Thus, Tbx5 is important 
for proper EPDC migration.
Figure 2. Phenotypic characterization of E9.5 Tbx5epi-/- 
embryos. A–F, Representative images of whole mount and 
sectioned E9.5 embryos. Whole mount wild-type (A) and Tbx5epi-/- 
mutant (D) embryos. Hematoxylin and eosin (H&E)–stained 
sections of wild-type (B) and Tbx5epi-/- mutant (E) embryos. 
Immunofluorescent detection of Wt1 (pink) in sectioned wild-
type (C) and Tbx5epi-/- (F) hearts. Nuclei counterstained with 
4,6-diamidino-2-phenylindole (blue). Scale bars, 500 μm (A and 
D) and 100 μm (B and E). Arrowheads (A and D) and asterisks  
(B, C, E, F) indicate proepicardium outlined by dashes. G–J, 
H&E-stained sections of E11.5 wild-type (G and H) and Tbx5epi-/- 
(I and J) hearts. Arrowheads indicate epicardium. Scale bar, 200 
μm (G–J). A indicates atrium; and V, ventricle.
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Migration of EPDCs into the myocardium occurs in a pat-
terned manner that involves several mechanisms, includ-
ing epicardial cell proliferation, survival,29,30 and EMT.31,32 
Despite the absence of altered proepicardial cell proliferation 
in E9.5 Tbx5epi-/- embryos, we observed a 42% reduction in 
Ki-67–positive proliferating epicardial cells in E12.5 Tbx5epi-/- 
embryos (Figure 4E and 4I) when compared with wild-types 
(Figure 4A and 4I). Examination of these hearts for potential 
EMT defects induced by proepicardial-specific deletion of 
Tbx5 did not reveal significant changes in the expression of the 
EMT markers Slug, Snail, and E-cadherin in E14.5 mutant ver-
sus wild-type embryos (not shown). These data demonstrate 
that proepicardial loss of Tbx5 produces developmental defects 
in the epicardium and EPDCs that may be precipitated by de-
layed epicardial cell adhesion to the myocardium and partially 
attributed to a reduction in epicardial cell proliferaton.
Figure 3. Altered migration of 
epicardial-derived cells into the 
myocardium of Tbx5epi-/- hearts. A–F, 
Immunohistochemical detection of Wt1-
positive epicardial cells (brown) in wild-
type (A–C) and Tbx5epi-/- (D–F) sectioned 
embryonic hearts at E12.5 (A and D), 
E13.5 (B and F), and E14.5 (C and F). 
Nuclei counterstained with hematoxylin 
(blue). Scale bars, 100 μm. Arrowheads 
denote Wt1-positive cells in the ventricle 
and epicardium. G, Quantification of Wt1-
positive cells in the compact myocardium 
of E14.5 wild-type (black bar; n=4) and 
Tbx5epi-/- (white bar; n=4) hearts. Data 
represented as mean±SEM. *P<0.05 vs 
wild-type. V indicates ventricle.
Figure 4. Altered cell behavior, thinned myocardium, and structural defects in Tbx5epi-/- hearts. A–H, Representative images of 
sectioned hearts. Immunofluorescent detection of Ki-67 (green) and cardiac actin (red) in E12.5 wild-type (A) and Tbx5epi-/- (E) hearts. 
Nuclei counterstained with 4,6-diamidino-2-phenylindole. Hematoxylin and eosin (H+E)–stained sections in E12.5 (B, C, F, G) or E15.5  
(D and H) wild-type (A–D) and Tbx5epi-/- (E–H) hearts. Myocardial wall thickness indicated by brackets. Arrowhead indicates epicardium  
(A and E) or ventricular septal defect (H). I, Quantification of Ki-67–positive epicardial cells in wild-type (black bar; n=4) and Tbx5epi-/- 
(white bar; n=4) hearts. Scale bars, 100 μm (A, C, E, G) and 500 μm (B, F, D, H). Data represented as mean+SEM. *P<0.05 vs wild-type.
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Structural Defects and Impaired Cardiac Growth in 
Tbx5epi-/- Mice
We did not observe gross morphological differences in whole 
mount embryos or hearts from E12.5 wild-type and Tbx5epi-/- 
mice. Normal formation of the compact myocardium was 
observed in hematoxylin and eosin–stained wild-type E12.5 
hearts (Figure 4B and 4C). However, we observed a thinned 
compact myocardium in E12.5 Tbx5epi-/- mice (Figure 4F and 
4G) in comparison with wild-type littermates. A comparison of 
Ki-67–positive cardiomyocytes in E12.5 wild-type versus mu-
tant mouse hearts revealed a 48% reduction in cardiomyocyte 
proliferation in Tbx5epi-/- hearts when compared with wild-type 
hearts (not shown). Terminal deoxynucleotidyl transferase 
dUTP nick end labeling assays of sectioned hearts did not 
reveal myocardial apoptosis in the hearts of E12.5 wild-type 
or Tbx5epi-/- embryos. However, myocardial apoptosis was ob-
served in E14.5 mutant hearts when compared with wild-types 
(not shown). In contrast to wild-type hearts (Figure 4D), mus-
cular and membranous ventricular septal defects were seen 
in 15% of E15.5 Tbx5epi-/- embryos (Figure 4H). Collectively, 
these myocardial defects may result from both a decrease in 
myocardial cell proliferation and the onset of cardiomyocyte 
apoptosis secondary to impaired epicardial formation and 
EPDC development in Tbx5epi-/- embryos.
Epicardial Inactivation of Tbx5 Affects 
Development of the EPDCs and Coronary 
Vasculogenesis
Gross inspection of E15.5 wild-type and Tbx5epi-/- mice re-
vealed areas of peripheral hemorrhage in mutant embryos 
(Online Figure VIE) that was not observed in wild-type lit-
termates (Online Figure VIA). Overall cardiac patterning was 
similar in both wild-type and mutant mice, but ventricular 
chamber size appeared to be reduced in Tbx5epi-/- versus wild-
type embryos. In contrast to E15.5 wild-type hearts (Online 
Figure VIB), Tbx5epi-/- hearts exhibited punctate areas of hem-
orrhaging (Online Figure VIF). Histology revealed abnormal 
vascular structures in mutant hearts. As opposed to E15.5 
wild-type hearts (Online Figure VIC), Tbx5epi-/- hearts exhibit-
ed epicardial cyst-like structures lined by delaminated epicar-
dium that were filled with erythrocytes (Online Figure VIG). 
Platelet endothelial cell adhesion molecule-1 immunostaining 
revealed a subepicardial accumulation of vessels in mutant 
hearts (Online Figure VIH) compared with wild-types (Online 
Figure VID). Together, these data are indicative of a coronary 
vascular defect in Tbx5epi-/- hearts.
Given that EPDCs differentiate into SMCs, cardiac fibro-
blasts, and endothelial cells,1,2,7,8 we determined the effects of 
proepicardial-specific deletion of Tbx5 on these cell popula-
tions. Histological analysis of E17.5 wild-type and Tbx5epi-/- 
hearts revealed nests of multiple contiguous subepicardial 
vessel-like structures that did not penetrate the myocardium 
of mutant hearts (Figure 5E) in contrast to wild-type hearts 
(Figure 5A). We determined that SMC recruitment to nascent 
coronary vessels was affected in Tbx5epi-/- hearts via immunohis-
tochemical analysis for SMC-specific protein (SM22α). SMCs 
formed a continuous layer surrounding the coronary vessels of 
E17.5 wild-type hearts (Figure 5B), whereas the SMC layer was 
either completely lost or discontinuous throughout the coronary 
vessels of Tbx5epi-/- hearts (Figure 5F). Immunostaining for peri-
ostin, a marker of the noncardiomyocyte lineage that is enriched 
in cardiac fibroblasts, revealed a reduced fibroblast invasion of 
the cardiac interstitium in E17.5 Tbx5epi-/- hearts (Figure 5G) 
when compared with wild-types (Figure 5C). Platelet endo-
thelial cell adhesion molecule-1 (CD31) immunostaining re-
vealed an elaborate ventricular capillary network in wild-type 
(Figure 5D) and Tbx5epi-/- hearts (Figure 5H). However, subse-
quent vessel quantification revealed a 45% reduction in platelet 
endothelial cell adhesion molecule-1–positive capillary density 
in Tbx5epi-/- hearts compared with wild-type hearts (Figure 5M). 
Together, these results suggest that a partial defect occurred 
during coronary vascular maturation in Tbx5epi-/- hearts that af-
fected SMC recruitment and caused reductions in formation of 
endothelial cells and other noncardiomyocytes that may include 
cardiac fibroblasts.
We sought to determine the physiological manifestations 
of these vascular developmental anomalies. In fact, we ob-
served hypoxia in Tbx5epi-/- mice. Compared with wild-type 
hearts (Figure 5I and 5J), E18.5 Tbx5epi-/- hearts displayed 
increased immunoreactivity for hypoxia inducible factor-1α 
(Figure 5K), as well as increased binding of hypoxyprobe-1 
(pimonidazole hydrochloride; Figure 5L), respectively. 
Hypoxyprobe-1 forms protein adducts in cells with a 
PO2<10 mm Hg. To determine the physiological consequences 
of this myocardial relative hypoxic state, we evaluated the max-
imal exercise capacity of Tbx5epi-/- mice. Twelve- to 16-week-
old Tbx5epi-/- mice were subjected to graded treadmill exercise 
testing.33 In contrast to wild-type mice, Tbx5epi-/- mice exhibited 
a significantly reduced maximal exercise tolerance (Figure 5N).
Transcriptome Analysis of Wild-Type and Tbx5epi-/- 
Mouse Hearts
To gain insight into Tbx5-dependent molecular pathways 
involved in epicardial and EPDC development during coro-
nary vasculogenesis, we characterized the transcriptome 
of E11.5 wild-type and Tbx5epi-/- hearts. Expression of 57 
genes was dysregulated in Tbx5epi-/- hearts (P<0.05). Among 
these dysregulated genes, 91.2% were downregulated and 
8.8% were upregulated in Tbx5epi-/- versus wild-type hearts 
(Figure 6A). Gene ontology analysis of significantly down-
regulated transcripts in Tbx5epi-/- mouse hearts revealed 
dysregulation of genes involved in vitamin A biosynthesis, 
cell adhesion, enhancer binding, RNA polymerase II tran-
scriptional activity, and developmental growth (Figure 6B). 
Genes encoding these biological functions, which correlate 
to retinoic acid signaling, gene transcription, development, 
and cell–cell interactions, contribute to epicardial and EPDC 
development.1,2,29,34–36 We previously observed focal regions 
of irregular, ruffled epicardium that were unattached to the 
myocardium in E11.5 Tbx5epi-/- hearts, but became attached 
by E12.5. Because changes in expression of cell adhesion and 
extracellular matrix (ECM) proteins could contribute to such 
abnormal epicardial integrity, we used quantitative reverse 
transcriptase-polymerase chain reaction to validate mRNA 
expression of the Ajap1, Frem3, and Reln genes encoding 
these cell adhesion and ECM proteins.37–39 Expression of 
these genes was significantly decreased in epicardial cells and 
EPDCs of E11.5 mutant versus wild-type hearts (Figure 6C) 
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and this may contribute to the delayed epicardial cell attach-
ment to the myocardium in these hearts.
Discussion
In this study, we demonstrate a conserved requirement for 
Tbx5 in avian and mammalian proepicardial development, as 
well as epicardial and coronary vascular formation and matura-
tion. We show that Tbx5 displays a dynamic expression pattern 
in embryonic proepicardial cell lineages and regulates devel-
opment of chick and mouse epicardial and coronary vascular 
progenitor cells from the PEO and epicardium, respectively. 
Moreover, genetically engineered loss of Tbx5 in the mouse 
proepicardium results in defective epicardial formation be-
cause of delayed epicardial cell adhesion to the myocardium 
and altered developmental gene expression. We believe that 
this consequently leads to impaired EPDC production and in-
vasion into the myocardium, compromised establishment of 
the coronary vasculature, decreased myocardial growth and 
myocardial hypoxia, and reduced maximal exercise tolerance 
in Tbx5epi-/- mice. We conclude that Tbx5 is indispensable for 
Figure 5. Defective epicardial-derived cell development and cardiac ischemia in Tbx5epi-/- mouse hearts. A–H, Representative 
images of Hematoxylin and eosin (H+E)–stained (A and E) and immunofluorescently stained sections of E17.5 wild-type (A–D) and 
Tbx5epi-/- (E–H) sectioned hearts. Immunofluorescent detection of the smooth muscle cell–specific protein (SM22α; B and F, green), 
periostin (C and G, green), cardiac actin (C and G, red), and platelet endothelial cell adhesion molecule-1 (PECAM-1)/CD31 (D and 
H, red). Nuclei couterstained with 4,6-diamidino-2-phenylindole (DAPI; B and F, blue). I–L, hypoxia inducible factor-1α (HIF1α) 
immunostaining (dark brown) of E18.5 wild-type (I) and Tbx5epi-/- (K) sectioned hearts. Nuclei counterstained with hematoxylin (blue). 
Hypoxyprobe-1 binding (green) on sectioned E18.5 wild-type (J) and Tbx5epi-/- mutant (L) hearts. Nuclei counterstained with DAPI (blue). 
M, Quantification of PECAM-1–positive vessels/high-powered field (HPF) in E17.5 wild-type (black bar; n=4) and Tbx5epi-/- (white bar; 
n=4) hearts. Data represent mean+SEM. *P<0.05 vs wild-type. N, Absolute maximum exercise tolerance quantified in 12- to 16-week-
old adult wild-type (black bar; n= 6) and Tbx5epi-/- (white bar; n=10) mice. Data represent mean±SEM; *P<0.05 vs wild-type. Scale bars, 
100 μm (A–L).
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normal epicardial formation and coronary vasculogenesis dur-
ing embryogenesis, and this requirement may be reflected in 
the pericardial agenesis and anomalous coronary arteries seen 
in human patients with HOS and defective TBX5.19,20
Loss of murine Tbx5 in the proepicardium did not prevent 
proepicardial cell specification and formation in Tbx5epi-/- 
mouse embryos as exhibited in zebrafish with mutant Tbx5.40 
The genetically heterogeneous nature of the proepicardium 
was recently demonstrated to have molecularly distinct expres-
sion domains7 and our expression analyses similarly suggest 
that Tbx5 expression is also heterogeneous throughout the de-
veloping proepicardium and epicardium. This may explain the 
normal specification and development of proepicardial cells 
in Tbx5epi-/- embryos. We will further explore this heterogene-
ity of Tbx5 expression in the proepicardium in future studies. 
Furthermore, we cannot exclude that other T-box transcription 
factors expressed in the proepicardium and EPDCs, such as 
Tbx1815, may partially compensate for the Tbx5 deficiency. 
Although proepicardial development is molecularly con-
served across species,40 we speculate that minor differences 
in Tbx5 expression and function occur during proepicardial 
development across species. This was exemplified by the lack 
of a functionally conserved requirement for Tbx5 between our 
embryonic chicks and mice in regulating proepicardial cell 
apoptosis. Although we observed some apoptotic migratory 
proepicardial cells outside of the TBX5-CXIZ–infected chick 
PEO explants, we did not observe apoptotic proepicardial cells 
in Tbx5epi-/- mouse embryos. We speculate that apoptosis is an 
epiphenomenon of altered chick Tbx5 gene dose that reflects 
the untimely fate of proepicardial cells with augmented cell 
migratory behavior. This may partially explain the reduced in-
corporation of EPDCs into the coronary vessels of hearts from 
E15 cTbx5As-CXL or TBX5-CXIZ–injected chick embryos.
The epicardial cell layer formed in E11.5 Tbx5epi-/- mice. 
However, its structural integrity appeared defective as ex-
hibited by an irregular, ruffled epicardium with focal regions 
that delayed attachment to the myocardium until E12.5. 
Transcriptome analysis of our E11.5 mouse hearts demon-
strated that proepicardium-specific deletion of Tbx5 altered 
several biological functions, including cell–cell interactions. 
Ajap1, Frem3, and Reln, which encode cell adhesion and ECM 
proteins, were among the downregulated genes identified in 
our Tbx5epi-/- mouse hearts. Epicardial cell adhesion to the 
myocardium is important for EPDC production and delamina-
tion into the subepicardial space, invasion into the myocar-
dium and coronary vasculogenesis.1,2,29,34–36 The contribution 
of these genes to cardiovascular development is unknown, 
but these structural adhesion molecules are known to medi-
ate cell–cell interactions in extracardiac tissues37–39 and, thus, 
we have identified novel genes involved in a Tbx5-dependent 
pathway of epicardial development. We think that downregu-
lation of these cell adhesion and ECM genes may contribute 
Figure 6. Altered cardiac gene expression with proepicardial-specific deletion of mouse Tbx5. A, Representation of the percentage 
of genes upregulated (red) or downregulated (blue) in hearts of E11.5 Tbx5epi-/- vs wild-type mice. B, Gene ontology analysis of 
significantly enriched biological processes displayed as –log base 10 (p value). C. Quantitative reverse transcriptase-polymerase chain 
reaction analysis of Ajap-1, Frem3, and Reln gene expression in epicardial cells and EPDCs of E11.5 wild-type (black bar; n=4) and 
Tbx5epi-/- hearts (white bar; n=4). Data represent mean±SEM, *P<0.05 vs wild-type.
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to the delayed epicardial cell attachment to the myocardium 
in Tbx5epi-/- hearts. Proper establishment of epicardial structure 
provides the foundation for subsequent EPDC development, 
delamination into the subepicardial space and myocardial in-
vasion to form coronary vessels. Thus, it is likely that the de-
fective epicardial structure of our Tbx5epi-/- embryonic hearts 
precipitated the decrease in EPDC production, impaired 
myocardial migration of EPDCs, and also perturbed coronary 
vasculogenesis. These findings are reminiscent of the struc-
tural and functional defects observed during epicardium and 
coronary vascular development of proepicardium-specific 
Tbx18-deficient mice, which similarly exhibited an irregu-
lar epicardial surface with frequent areas distended from the 
myocardium, as well as subepicardial nodules containing 
erythroblasts.15 EPDC invasion of the myocardium involves 
several mechanisms, including epicardial cell proliferation, 
survival,29,30 and EMT.31,32 Although expression of EMT and 
apoptotic markers was unaffected by proepicardium-specific 
deletion of Tbx5 in our mice, epicardial cell proliferation was 
significantly reduced in E12.5 Tbx5epi-/- embryos. Tbx5 has 
been previously shown to regulate cell proliferation during 
morphogenesis of tissues, including the vertebrate heart.27,41 
The diminished epicardial cell proliferation observed in our 
mutant mice may underlie the impaired production of EPDCs 
given that epicardial cell proliferation is intricately linked to 
EPDC invasion of the myocardium.30,42 Thus, we think that 
the impaired EPDC development in our Tbx5epi-/- embryos is 
a consequence of a suboptimal environment previously estab-
lished by delayed epicardial cell adhesion to the myocardium 
and this is compounded by reduced epicardial cell prolifera-
tion. The resultant inability of EPDCs to invade the myocar-
dium is consistent with previous reports of altered deposition 
of adhesion molecules during mammalian cardiogenesis 
that hindered EPDC migration into the ventricular myocar-
dium.29,34,43,44 Altogether, these data indicate that Tbx5 expres-
sion is critical for establishing normal epicardial structure and 
subsequent EPDC production.
EPDCs contribute to the formation of SMCs, endothelial 
cells, and cardiac fibroblasts in avian and murine hearts during 
coronary vasculogenesis.1,2,7,45 In fetal Tbx5epi-/- mouse hearts, 
we observed impaired SMC recruitment and a reduction in 
endothelial cells and cardiac fibroblasts. Our data demonstrate 
that impaired development of these lineages subsequently 
leads to abnormal coronary vasculogenesis in Tbx5epi-/- hearts. 
Further analysis will need to be performed to determine wheth-
er Tbx5 acts directly or indirectly to influence differentiation 
of these lineages. However, we speculate that delayed epicar-
dial cell attachment to the myocardium precipitates a cascade 
of events that lead to abnormal coronary vasculogenesis in 
Tbx5epi-/- hearts. Our data collectively support a model in which 
proepicardium-specific Tbx5 deficiency inhibits expression of 
cell adhesion and ECM proteins and delays epicardial cell at-
tachment to the myocardium to disrupt epicardium integrity. 
The epicardium defect is made worse by reduced epicardial 
cell proliferation. As a result, EPDC production, delamination 
into the subepicardial space, and myocardial invasion are im-
paired. Together, these events contribute to abnormal coronary 
vasculogenesis in Tbx5epi-/- embryos. In addition, Tbx5epi-/- mice 
exhibit hypoplastic ventricular trabeculation and 15% of mice 
display ventricular septal defects consistent with paracrine ef-
fects of the epicardium on stimulating myocardial growth and 
development. To our knowledge, Tbx5epi-/- mice represent the 
first proepicardium-specific deletion mouse model to exhibit 
cardiac septation defects. Atrial septal defects caused by apop-
tosis or reduced cell proliferation were previously observed on 
Tbx5 deletion in the endocardium46 or posterior second heart 
field,41 respectively. Therefore, it is plausible that EPDCs dis-
play similar non cell-autonomous growth-promoting activities 
on the interventricular septum. In addition, our analysis of 
Wt1 expression in the developing mouse heart documented 
the presence of Wt1-positive EPDCs in the interventricular 
septum, and reports have raised the possibility that EPDCs 
may differentiate into cardiomyocytes in the interventricular 
septum.1,8 Thus, septation defects observed in mice with ubiq-
uitous Tbx5 deficiency and in patients with HOS may result 
from reduced Tbx5 activity in the myocardium, as well as in 
the proepicardium and epicardium.19–21
Proepicardial-specific loss of Tbx5 in mice causes embryon-
ic lethality that may result from cumulative effects on coronary 
vasculogenesis and epicardial cell growth and survival to, sub-
sequently, impose myocardial growth defects that alter cardiac 
structure. Defective coronary vasculogenesis leads to ischemic 
cardiomyopathy in adult Tbx5epi-/- mice. These mice exhibit rest-
ing hypoxia and exercise-induced ischemia. It is not uncommon 
for human adults to present with poorly explained cardiomy-
opathy long after childhood repair of congenital heart malfor-
mations, and patients with HOS have been reported to develop 
diastolic ventricular dysfunction even after repair of septation 
defects.47 Ischemia is a well-recognized cause of reduced ven-
tricular compliance, and thus subclinical microvascular hypo-
plasia in HOS may contribute to chronic ischemia and the late 
onset cardiomyopathy that has been observed. On the basis of 
our observations that augmentation of chick and murine Tbx5 
affects proepicardial development, disrupts epicardial structural 
integrity, impairs EPDC development, and decreases vascular 
investment of the myocardium, we conclude that Tbx5 is indis-
pensable for normal epicardial and coronary vascular formation 
during embryogenesis. This requirement for Tbx5 in mouse and 
chick epicardial development may be reflected in the pericardial 
agenesis and anomalous coronary arteries seen in human pa-
tients with HOS and defective TBX5.19,20 Additional studies will 
determine the combined effects of epicardial and myocardial 
Tbx5 activity to dissect pathways in normal cardiogenesis and 
the phenotypes of patients with HOS.
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What Is Known?
•	 The proepicardial organ/proepicardium is a grape-like structure locat-
ed caudal to the heart that contributes precursor cells during cardio-
vascular development to form the epicardium, pericardium, coronary 
vessels, and cardiac fibroblasts through a series of coordinated events 
involving regulation of gene expression and cell behavior.
•	 During cardiovascular development, Tbx5 mRNA is detected in the em-
bryonic chick proepicardial organ, and TBX5 protein is expressed in the 
epicardium and coronary vessels of the fetal human heart.
•	 TBX5 overexpression in the proepicardial organ disrupts proepicardial 
cell migration to the coronary vasculature in the embryonic chick heart, 
whereas loss of Tbx5 in the developing zebrafish heart leads to the 
absence of proepicardium formation.
What New Information Does This Article Contribute?
•	 We developed strategies to investigate Tbx5 activity in formation and 
maturation of the epicardium and coronary vessels through retroviral-
mediated transgenesis in the embryonic chick and tissue-specific de-
letion of Tbx5 in the developing mouse proepicardium.
•	 Our findings reveal that proepicardium -specific loss of mouse Tbx5 
causes delayed epicardial attachment to the myocardium and sub-
epicardial accumulation of epicardial-derived cells that, we believe, 
precipitates a cascade of events to impair epicardial maturation and 
formation of the coronary vasculature, inhibit cardiac growth, and elicit 
myocardial hypoxia in the mammalian heart.
•	 Tbx5 is indispensable for normal epicardial formation and coronary 
vasculogenesis during embryogenesis and this may be reflected by the 
pericardial agenesis and anomalous coronary arteries seen in some 
human patients with Holt–Oram syndrome and TBX5 mutations.
Previous studies identified Tbx5 roles in myocardial, endocardial, 
and cardiac conduction system development. However, potential 
Tbx5 activity in the epicardium and mammalian coronary vasculo-
genesis remains unidentified. We show that Tbx5 expression in the 
proepicardium and epicardium is heterogeneous. Our augmentation 
of Tbx5 expression in embryonic chick proepicardial organ and epi-
cardium reveals its requirement in proepicardial cell migration for 
formation and maturation of the epicardium and incorporation of 
epicardial-derived cells into coronary blood vessels. Mice genetical-
ly engineered for proepicardial-specific Tbx5 loss (Tbx5epi-/-) are born 
at sub-Mendelian ratios. Although the proepicardium forms properly 
in these mice and proepicardial cells begin migration toward the 
myocardium at embryonic day (E)10.5, Tbx5 deficiency delays epi-
cardial cell attachment to the E11.5 myocardium. Cell adhesion and 
extracellular matrix gene expression are reduced in E11.5 Tbx5epi-/- 
hearts. Although epicardial cells attach to myocardium by E12.5, 
Tbx5epi-/- embryos exhibit other defects, including impaired epicardi-
al-derived cell production and invasion into the myocardium, com-
promised establishment of coronary vessels, decreased myocardial 
growth and myocardial hypoxia. Adult Tbx5epi-/- mice are intolerant 
to exercise. We conclude that Tbx5 is required in normal epicardial 
formation and coronary vasculogenesis. This requirement provides 
insight into pericardial agenesis and anomalous coronary arteries 
observed in patients with HOS and TBX5 mutations.
Novelty and Significance
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